Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Antithrombotic Activities of Sotagliflozin vs. Empagliflozin [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating the antithrombotic activities of sotagliflozin compared with empagliflozin. The study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)
  • Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Thrombosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING